Atom | Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections

Due Dates: September 16, 2025 (single-stage)

Funding Amounts: ~€15,000,000 per project; up to 3 projects funded; lump sum model

Summary: Supports multicenter clinical trials to establish the safety and efficacy of phage therapies for antibiotic-resistant bacterial infections, aiming to advance regulatory approval and clinical adoption.

Key Information: Open to international consortia; SME and social sciences participation strongly encouraged; strict data and regulatory requirements.

Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections

Sign in to see full grant listing